BHCM
CC icon

Brevan Howard Capital Management’s Chemours CC Stock Holding History

Brevan Howard Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Sell
28,340
-40,804
-59% -$934K ﹤0.01% 1373
2026
Q1 		$1.52M Buy
+69,144
New +$1.2M 0.01% 688
2025
Q4 		– Sell
-16,740
Closed -$265K – 1846
2025
Q3 		$265K Sell
16,740
-282,603
-94% -$4.1M ﹤0.01% 1630
2025
Q2 		$3.43M Buy
+299,343
New +$3.37M 0.02% 521

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Brevan Howard Capital Management's CC Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Chemours (CC) stake by 59% in Q2 2026, selling an estimated $934K and leaving 28,340 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Brevan Howard Capital Management first reported a position in CC in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.43M in Q2 2025. 471 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Brevan Howard Capital Management held 28,340 shares of Chemours worth $582K as of Q2 2026.
  • Brevan Howard Capital Management sold 40,804 Chemours shares in Q2 2026, an estimated $934K.
  • Chemours made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1373 holding.
  • Brevan Howard Capital Management first reported a position in Chemours in Q2 2025 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's Chemours position peaked at $3.43M in Q2 2025.
  • 471 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.